Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Conde

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|September 16, 2011
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma riskDaniele Campa, Katja Butterbach, Susan L Slager, et al.
Nature Cancer|November 4, 2021
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemiaVirginia A Turati, José Afonso Guerra-Assunção, Nicola E Potter, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.
British Journal of Haematology|October 3, 2012
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypesSusan L Slager, Nicola J Camp, Lucia Conde, et al.
Disease Models & Mechanisms|November 11, 2025
Impaired nuclear PTEN function drives macrocephaly, lymphadenopathy and late-onset cancer in PTEN hamartoma tumour syndromePriyanka Tibarewal, Victoria Rathbone, Sarah E Conduit, et al.
Cancer Causes & Control : CCC|November 20, 2012
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortiumTodd M Gibson, Karin E Smedby, Christine F Skibola, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Blood|October 11, 2012
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortiumAlexandra Nieters, Lucia Conde, Susan L Slager, et al.
Blood|April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|September 16, 2011
A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma riskDaniele Campa, Katja Butterbach, Susan L Slager, et al.
Nature Cancer|November 4, 2021
Chemotherapy induces canalization of cell state in childhood B-cell precursor acute lymphoblastic leukemiaVirginia A Turati, José Afonso Guerra-Assunção, Nicola E Potter, et al.
Cell|January 28, 2021
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibitionKevin Litchfield, James L Reading, Clare Puttick, et al.
Cell|April 15, 2021
Glioblastomas acquire myeloid-affiliated transcriptional programs via epigenetic immunoediting to elicit immune evasionEster Gangoso, Benjamin Southgate, Leanne Bradley, et al.
British Journal of Haematology|October 3, 2012
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypesSusan L Slager, Nicola J Camp, Lucia Conde, et al.
Disease Models & Mechanisms|November 11, 2025
Impaired nuclear PTEN function drives macrocephaly, lymphadenopathy and late-onset cancer in PTEN hamartoma tumour syndromePriyanka Tibarewal, Victoria Rathbone, Sarah E Conduit, et al.
Cancer Causes & Control : CCC|November 20, 2012
Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortiumTodd M Gibson, Karin E Smedby, Christine F Skibola, et al.
Blood|June 16, 2012
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemiaSusan L Slager, Christine F Skibola, Maria Chiara Di Bernardo, et al.
Blood|October 11, 2012
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortiumAlexandra Nieters, Lucia Conde, Susan L Slager, et al.
Blood|April 21, 2018
Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosisGeffen Kleinstern, Nicola J Camp, Lynn R Goldin, et al.
Pageof 7